<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="109.html"><span>right</span></a></div>
</header>

<div class="wrap">
  <div class="clearfix">
<img src="img04/ver4.png" alt="ver4" width="50" height="20" style="float: right;">
</div>
  <!--タイトルエリア-->
  <section>
    <h1 class="tit">参考：AMBITION,ADACTA,RADIATEにおけるPROs改善報告</h1>
  </section>
  <!--タイトルエリア-->

  <!--ボックス-->
  <section>
    <p class="txt big center"><font color="red"><strong>ACTは様々な対象の患者さん、治療法との比較においてPROs改善データを有する</strong></font></p>
    <p class="text"><strong> MTX-naïve</strong></p>
    <div class="img"><img src="img04/108-1.png" alt=""></div>

    <p class="text"><strong> MTX-IR</strong></p>
    <div class="img"><img src="img04/108-2.png" alt=""></div>

    <p class="text"><strong> TNF-IR</strong></p>
    <div class="img"><img src="img04/108-3.png" alt=""></div>

    <p class="text sml left">・Vibeke Strand et al , ACR2016 #2515</p>
    <p class="text sml left"><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Rheumatology.+2012+Oct+51+tocilizumab+Vibeke+Strand">・Rheumatology (Oxford). 2012 Oct;51(10)</a></p>

    <p class="text sml right">各試験におけるLSM（最少二乗平均）変化</p>






  </section>
  <!--ボックス-->
</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="109.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
